Cymabay Therapeutics(CBAY)
32.48 0.00 0.0%
| 今开：0.0 | 昨收：32.48 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.726247895E9 |
Cymabay Therapeutics的热门讨论
其他
Cymabay Therapeutics(CBAY)02-13 06:35
$Cymabay Therapeutics(CBAY)$ SC14D9C Written communication relating to third party tender offer Accession Number: 0001193125-24-032309 Act: 34 Size: 312 KB 网页链接查看全文
美股滚雪球02-27 11:25
并购要趁早，不然股价涨上来了，要价就高了，比如$吉利德科学(GILD)$ 与$Cymabay Therapeutics(CBAY)$ ：
November 20: GILD offers $23.00/share
January 25: GILDoffers $31.00/share plus a CVR of up to $2.50/share
January 30: GILD offers $32.50/share，January 31: CBAY ask...查看全文
其他
Cymabay Therapeutics(CBAY)03-23 04:45
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075358 Act: 33 Size: 36 KB 网页链接查看全文
其他
Cymabay Therapeutics(CBAY)03-23 04:55
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075399 Act: 33 Size: 36 KB 网页链接查看全文
其他
Cymabay Therapeutics(CBAY)03-23 04:55
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075382 Act: 33 Size: 36 KB 网页链接查看全文
其他
Cymabay Therapeutics(CBAY)03-23 05:05
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075403 Act: 33 Size: 36 KB 网页链接查看全文
年度财报
Cymabay Therapeutics(CBAY)02-29 05:45
$Cymabay Therapeutics(CBAY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-050758 Act: 34 Size: 11 MB 网页链接查看全文
其他
Cymabay Therapeutics(CBAY)02-29 06:15
$Cymabay Therapeutics(CBAY)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-24-050789 Act: 34 Size: 91 KB 网页链接查看全文
其他
Cymabay Therapeutics(CBAY)02-29 06:35
$Cymabay Therapeutics(CBAY)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-24-028791 Act: 34 Size: 40 KB 网页链接查看全文
超过5%股东持股披露「修订」
Cymabay Therapeutics(CBAY)02-15 05:15
$Cymabay Therapeutics(CBAY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006622 Act: 34 Size: 77 KB 网页链接查看全文
Cymabay Therapeutics的最新讨论
chuminhua2020-07-24 19:20
7/23，Cymabay$Cymabay Therapeutics(CBAY)$ 在其官网宣布FDA决定解除seladelpar的临床研究停止令，涉及该药物的三个IND临床研究包括非酒精性脂肪肝（NASH），原发性胆汁胆管炎（PBC）和原发性硬化性胆管炎（PSC）。受此利好，公司股价上涨25%。Seladelpar是一款口服PPARδ激动剂，可以靶向肝脏疾...查看全文
![[买]](http://js.xueqiu.com/ugc/images/face/emoji_54_buy.png?v=1 "[买]"){kind=small}
点试试吴汉靓2020-05-13 23:21
之前写过一些ppar激动剂，发现昨天晚上真是上演了悲喜剧：Genfit的ppar在NASH领域的III期未达临床终点；Cymabay的ppar又重燃在NASH的希望
$Genfit(GNFT)$ $Cymabay Therapeutics(CBAY)$查看全文
装逼备忘录2020-05-13 04:31
$Cymabay Therapeutics(CBAY)$ 股价今天下午上涨128.26%，因市场预期FDA将取消对NASH治疗的限制。这一增长使Cymabay疗法在我们所有美国交易所的变化百分比进步列表中名列前茅。查看全文
![[赚大了]](http://js.xueqiu.com/ugc/images/face/emoji_06_money.png?v=1 "[赚大了]"){kind=small}
美股律师郝俊波2020-03-03 14:06
$Cymabay Therapeutics(CBAY)$ CymaBay Therapeutics Inc(NASDAQ: CBAY)因连续大幅下跌令投资者损失严重，如果您投资该证券受损请点击我们的雪球网相关集体诉讼专题页：网页链接查看全文
chuminhua2019-11-27 13:05
11/25，CymaBay Therapeutics$Cymabay Therapeutics(CBAY)$ 终止了肝病药物seladelpar所有用于原发性胆管性胆管炎（PBC）的研究，原因是在非酒精性脂肪性肝炎（NASH）和原发性硬化性胆管炎（PSC）的中期研究中发现某些患者出现肝损伤。该公司股价暴跌75%。查看全文
Cymabay Therapeutics的公告
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035468 Size: 10 KB 网页链接
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035470 Size: 30 KB 网页链接
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035474 Size: 24 KB 网页链接
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035447 Size: 34 KB 网页链接
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035446 Size: 12 KB 网页链接
其他
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075403 Act: 33 Size: 36 KB 网页链接
其他
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075404 Act: 33 Size: 36 KB 网页链接
持股变动声明
$Cymabay Therapeutics(CBAY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035448 Size: 32 KB 网页链接
其他
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075406 Act: 33 Size: 36 KB 网页链接
其他
$Cymabay Therapeutics(CBAY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-24-075407 Act: 33 Size: 36 KB 网页链接